Total Payments
$334,735
2024 Payments
$45,699
Companies
12
Transactions
33
Medicare Patients
4,682
Medicare Billing
$412,412
Payment Breakdown by Category
Consulting$334,333 (99.9%)
Food & Beverage$402.30 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $334,333 | 17 | 99.9% |
| Food and Beverage | $402.30 | 16 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dermavant Sciences, Inc. | $334,333 | 17 | $0 (2024) |
| Allergan Inc. | $86.12 | 1 | $0 (2017) |
| Galderma Laboratories, L.P. | $71.75 | 4 | $0 (2021) |
| Lilly USA, LLC | $53.67 | 2 | $0 (2022) |
| ABBVIE INC. | $44.37 | 2 | $0 (2023) |
| LEO Pharma Inc. | $32.05 | 1 | $0 (2022) |
| PFIZER INC. | $28.55 | 1 | $0 (2021) |
| DERMIRA, INC. | $22.92 | 1 | $0 (2021) |
| Janssen Biotech, Inc. | $16.87 | 1 | $0 (2021) |
| Solta Medical, a division of Bausch Health US, LLC | $16.62 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $45,699 | 4 | Dermavant Sciences, Inc. ($45,684) |
| 2023 | $284,092 | 14 | Dermavant Sciences, Inc. ($284,069) |
| 2022 | $4,656 | 4 | Dermavant Sciences, Inc. ($4,580) |
| 2021 | $147.88 | 7 | Galderma Laboratories, L.P. ($41.72) |
| 2020 | $35.96 | 2 | Lilly USA, LLC ($24.88) |
| 2018 | $18.95 | 1 | Galderma Laboratories, L.P. ($18.95) |
| 2017 | $86.12 | 1 | Allergan Inc. ($86.12) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Consulting Fee | Cash or cash equivalent | $1,316.00 | General |
| Category: DERMATOLOGY | ||||||
| 03/01/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Dermatology | ||||||
| 01/31/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Consulting Fee | Cash or cash equivalent | $4,368.00 | General |
| Category: DERMATOLOGY | ||||||
| 01/03/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/03/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| Category: DERMATOLOGY | ||||||
| 10/03/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| Category: DERMATOLOGY | ||||||
| 09/06/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Consulting Fee | Cash or cash equivalent | $41,504.74 | General |
| Category: DERMATOLOGY | ||||||
| 08/02/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| Category: DERMATOLOGY | ||||||
| 07/05/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| Category: DERMATOLOGY | ||||||
| 06/05/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Consulting Fee | Cash or cash equivalent | $11,944.00 | General |
| Category: DERMATOLOGY | ||||||
| 05/02/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Consulting Fee | Cash or cash equivalent | $6,024.00 | General |
| Category: DERMATOLOGY | ||||||
| 04/04/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Consulting Fee | Cash or cash equivalent | $6,800.00 | General |
| Category: DERMATOLOGY | ||||||
| 03/04/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Consulting Fee | Cash or cash equivalent | $4,620.00 | General |
| Category: DERMATOLOGY | ||||||
| 02/06/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: IMMUNOLOGY | ||||||
| 02/02/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Consulting Fee | Cash or cash equivalent | $8,680.00 | General |
| Category: DERMATOLOGY | ||||||
| 01/06/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Consulting Fee | Cash or cash equivalent | $2,260.00 | General |
| Category: DERMATOLOGY | ||||||
| 01/04/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Consulting Fee | Cash or cash equivalent | $2,236.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/16/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $32.05 | General |
| Category: DERMATOLOGY | ||||||
| 11/01/2022 | Dermavant Sciences, Inc. | VTAMA (Drug) | Consulting Fee | Cash or cash equivalent | $4,580.00 | General |
| Category: DERMATOLOGY | ||||||
| 10/26/2022 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: Immunology | ||||||
| 02/16/2022 | MAYNE PHARMA INC. | — | Food and Beverage | In-kind items and services | $14.78 | General |
| 12/15/2021 | Solta Medical, a division of Bausch Health US, LLC | — | Food and Beverage | In-kind items and services | $16.62 | General |
| 10/05/2021 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $19.88 | General |
| 09/16/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 696 | 1,220 | $139,285 | $41,073 |
| 2022 | 18 | 1,939 | 4,185 | $534,941 | $182,214 |
| 2021 | 15 | 1,421 | 2,900 | $388,041 | $136,682 |
| 2020 | 9 | 626 | 1,105 | $145,264 | $52,442 |
Total Patients
4,682
Total Services
9,410
Medicare Billing
$412,412
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 152 | 177 | $31,651 | $8,783 | 27.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 99 | 109 | $21,679 | $6,460 | 29.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 65 | 69 | $15,369 | $5,120 | 33.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 119 | 137 | $18,173 | $4,195 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 51 | $12,942 | $3,745 | 28.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 24 | 31 | $10,346 | $3,648 | 35.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 52 | 52 | $11,688 | $3,037 | 26.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 91 | 532 | $6,855 | $2,523 | 36.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $6,327 | $1,803 | 28.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 30 | 43 | $4,255 | $1,758 | 41.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 310 | 485 | $88,270 | $31,329 | 35.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 194 | 297 | $76,032 | $27,496 | 36.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 223 | 304 | $61,712 | $20,798 | 33.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 270 | 440 | $58,960 | $16,851 | 28.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 164 | 209 | $47,025 | $16,653 | 35.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 191 | 191 | $43,166 | $11,931 | 27.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 55 | 88 | $29,480 | $11,648 | 39.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 108 | 108 | $36,504 | $10,843 | 29.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 213 | 1,747 | $22,961 | $9,253 | 40.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 83 | 141 | $14,375 | $5,976 | 41.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 34 | 49 | $17,493 | $5,875 | 33.6% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2022 | 16 | 19 | $16,283 | $5,654 | 34.7% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2022 | 12 | 12 | $9,624 | $3,160 | 32.8% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2022 | 16 | 16 | $6,048 | $2,451 | 40.5% |
| 69100 | Biopsy of ear | Office | 2022 | 15 | 16 | $3,104 | $847.20 | 27.3% |
About Dr. Brandon Kirsch, MD
Dr. Brandon Kirsch, MD is a Dermatology healthcare provider based in Naples, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2013. The National Provider Identifier (NPI) number assigned to this provider is 1861836389.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brandon Kirsch, MD has received a total of $334,735 in payments from pharmaceutical and medical device companies, with $45,699 received in 2024. These payments were reported across 33 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($334,333).
As a Medicare-enrolled provider, Kirsch has provided services to 4,682 Medicare beneficiaries, totaling 9,410 services with total Medicare billing of $412,412. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Naples, FL
- Active Since 04/26/2013
- Last Updated 11/30/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1861836389
Products in Payments
- VTAMA (Drug) $334,333
- RHOFADE (Drug) $86.12
- TALTZ (Drug) $53.67
- ADBRY (Biological) $32.05
- EUCRISA (Drug) $28.55
- RINVOQ (Biological) $23.17
- QBREXZA (Drug) $22.92
- SKYRIZI (Biological) $21.20
- TREMFYA (Drug) $16.87
- XTRAC (Device) $14.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Naples
Cynthia Yag Howard, Md, MD
Dermatology — Payments: $16,365
Dermatology $16,365
Dr. Craig Eichler, M.d, M.D
Dermatology — Payments: $12,253
Dermatology $12,253
Dr. Frances Hernandez, Md, MD
Dermatology — Payments: $6,018
Dermatology $6,018
Daniel Wasserman, M.d, M.D
Dermatology — Payments: $5,283
Dermatology $5,283
Dr. Anne Tremaine, M.d, M.D
Dermatology — Payments: $4,467
Dermatology $4,467
Christina Tremblay, Pa-C, PA-C
Dermatology — Payments: $3,862
Dermatology $3,862